Epidural hematomas after removal of percutaneous spinal cord stimulator trial leads: Two case reports

Regional Anesthesia and Pain Medicine

Volumn 39, Issue 1, 2014, Pages 73-77

  Giberson, Curren E ^a   Barbosa, Judith ^a   Brooks, Elizabeth S ^a   Mcglothlen, Gail L ^b   Grigsby, Eric J ^b   Kohut, James J ^c   Wolbers, Linda L ^a   Poree, Lawrence R ^d  

^a Pain Clinic of Monterey Bay   (United States)

^b Napa Pain Institute   (United States)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

^d Pain Clinic of Monterey Bay   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROCODONE; LORAZEPAM; MORPHINE; STEROID;

ADULT; AGED; ARTICLE; BACKACHE; CASE REPORT; DEVICE REMOVAL; DISEASE SEVERITY; EMERGENCY WARD; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LAMINECTOMY; LEG; MALE; MIDDLE AGED; NEUROMODULATION; NEUROSURGEON; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PRIORITY JOURNAL; SPINAL CORD COMPRESSION; SPINAL CORD STIMULATOR; SPINAL HEMATOMA; STEROID THERAPY; THORAX PAIN; WEAKNESS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CLINICAL TRIALS AS TOPIC; DEVICE REMOVAL; HEMATOMA, EPIDURAL, SPINAL; HUMANS; MALE; MIDDLE AGED; SPINAL CORD STIMULATION; TIME FACTORS;

EID: 84892145364     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0000000000000026     Document Type: Article

References (41)

1. Turner JA, Loeser JD, Bell KG. Spinal cord stimulation for chronic low back pain: A systematic literature synthesis. Neurosurgery. 1995;37: 1088-1095
2. Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: A 20-year literature review. J Neurosurg. 2004;100:254-267
3. Zan E, Kurt KN, Yousem DM, Christo PJ. Spinal cord stimulators: Typical positioning and postsurgical complications. AJR Am J Roentgenol. 2011;196:437-445
4. Levy R, Henderson J, Slavin K, et al. Incidence and avoidance of neurologic complications with paddle type spinal cord stimulation leads. Neuromodulation. 2011;14:412-422
5. Franzini A, Ferroli P, Marras C, Broggi G. Huge epidural hematoma after surgery for spinal cord stimulation. Acta Neurochir (Wien). 2005;147:565-567
6. Takawira N, Han RJ, Nguyen TQ, Gaines JD, Han TH. Spinal cord stimulator and epidural haematoma. Br J Anaesth. 2012;109: 649-650
7. Kloss BT, Sullivan AM, Rodriguez E. Epidural hematoma following spinal cord stimulator implant. Int J Emerg Med. 2010;3:483-484
8. Smith CC, Lin JL, Shokat M, Dosanjh SS, Casthely D. A report of paraparesis following spinal cord stimulator trial, implantation and revision. Pain Physician. 2010;13:357-363
9. Santiago FM, Santiago J, Prieto M, et al. [Dorsal epidural hematoma after implantation of a dorsal nerve stimulator]. Rev Esp Anestesiol Reanim. 2005;52:440-441
10. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35:64-101
11. Deer TR, Prager J, Levy R et al. Polyanalgesic Consensus Conference - 2012: Recommendations on trialing for intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation. 2012;15:420-435
12. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975;56:624-632
13. Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest. 1978;61:314-319
14. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982;69:1366-1372
15. Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80:303-309
16. Horlocker TT, Bajwa ZH, Ashraf Z, et al. Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg. 2002;95: 1691-1697
17. Vane Jr. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232-235
18. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69-102
19. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975;72:2994-2998
20. Fitzpatrick FA. Cyclooxygenase enzymes: Regulation and function. Curr Pharm Des. 2004;10:577-588
21. Roth GJ, Siok CJ. Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin. J Biol Chem. 1978;253: 3782-3784
22. Roth GJ, Machuga ET, Ozols J. Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase. Biochemistry. 1983;22:4672-4675
23. Paulus JM. Multiple differentiation in megakaryocytes and platelets. Blood. 1967;29:407-416
24. van Pampus EC, Huijgens PC, Zevenbergen A, et al. Influence of aspirin on human megakaryocyte prostaglandin synthesis. Eur J Haematol. 1993;50:264-268
25. Cazenave JP, Gachet C. Anti-platelet drugs: Do they affect megakaryocytes? Baillieres Clin Haematol. 1997;10:163-180
26. Bradlow BA, Chetty N. Dosage frequency for suppression of platelet function by low dose aspirin therapy. Thromb Res. 1982;27:99-110
27. Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985;72:1177-1184
28. Li C, Hirsh J, Xie C, Johnston MA, Eikelboom JW. Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost. 2012;10:521-528
29. Zisman E, Erport A, Kohanovsky E, et al. Platelet function recovery after cessation of aspirin: Preliminary study of volunteers and surgical patients. Eur J Anaesthesiol. 2010;27:617-623
30. Rocca B, Santilli F, Pitocco D, et al. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Haemost. 2012;10:1220-1230
31. De Caterina R, Sicari R, Yan A, et al. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man. Thromb Haemost. 1992;67:258-263
32. McIntyre BA, Philp RB, Inwood MJ. Effect of ibuprofen on platelet function in normal subjects and hemophiliac patients. Clin Pharmacol Ther. 1978;24:616-621
33. Nadell J, Bruno J, Varady J, Segre EJ. Effect of naproxen and of aspirin on bleeding time and platelet aggregation. J Clin Pharmacol. 1974;14: 176-182
34. Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost. 2008;34:709-733
35. Ng KF, Lawmin JC, Tsang SF, Tang WM, Chiu KY. Value of a single preoperative PFA-100 measurement in assessing the risk of bleeding in patients taking cyclooxygenase inhibitors and undergoing total knee replacement. Br J Anaesth. 2009;102:779-784
36. Sucker C, Litmathe J, Feindt P, Zotz R. Platelet function analyzer (PFA-100) as a useful tool for the prediction of transfusion requirements during aortic valve replacement. Thorac Cardiovasc Surg. 2011; 59:233-236
37. Thaler HW, Frisee F, Korninger C. Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery. J Trauma. 2010;69:1217-1220
38. Prohaska W, Zittermann A, Inoue K, et al. Preoperative haemostasis testing does not predict requirement of blood products in cardiac surgery. Eur J Med Res. 2008;13:525-530
39. Fattorutto M, Pradier O, Schmartz D, Ickx B, Barvais L. Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? Br J Anaesth. 2003;90:692-693
40. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79:1165-1177
41. Lawton MT, Porter RW, Heiserman JE, et al. Surgical management of spinal epidural hematoma: Relationship between surgical timing and neurological outcome. J Neurosurg. 1995;83:1-7